325 CAPITAL LLC

325 Capital LLC sells 160,512 shares (160.5K shares) of APEI for $8,726,076.81 over two days at blended average $54.36

325 Capital LLC executed 5 separate sales totaling 160,512 shares for $8,726,076.81 between 2026-03-19 and 2026-03-20, reducing holdings from 996,746 shares to 836,234 shares (a -16.1% reduction). The sales occurred at prices ranging from $53.74 to $55.55, with a blended average of $54.36, near the current price of $55.49. At APEI specifically, the insider has sold on 5 prior occasions within the last year, with two measurable outcomes showing the stock rose 7.8% and 7.1% over 30 days following those earlier sells (and +13.1% and +11.3% over 90 days), indicating prior sells were not well-timed; the insider sold before gains materialized. The cross-ticker track record shows 12 prior sells with a 0.00% well-timed rate overall, meaning all prior sells were followed by gains rather than declines. With annual revenue growth of only +3.9% and a P/E of 21.51, the company's valuation context provides limited support for characterizing this sale as a material confidence signal.

325 Capital LLC sold 184,259 shares of APEI for $10,237,843.53 over 3 days at $55.56 avg, reducing stake 15.6%

325 Capital LLC executed 3 separate sales totaling 184,259 shares for $10,237,843.53 across March 16–18, 2026, at a blended average price of $55.56, reducing holdings from 1.18M to 996.7K shares. The sales occurred while APEI was near its 52-week high of $57.66, having climbed 41.4% over the prior 90 days and 21.8% over the prior 30 days. Notably, 325 Capital's prior 5 sales at APEI generated positive 90-day returns in every case (ranging from 2.9% to 13.1%), with 0 of 5 being well-timed by the metric of selling before subsequent declines. The current stock price of $54.32 sits 5.8% below the 52-week high, within the price window where these recent sales executed. This sale represents the largest single liquidation event in the insider's APEI trade history and occurs at valuations substantially above the stock's baseline, warranting observation of whether subsequent price action aligns with or diverges from the insider's recent disposition.

325 Capital LLC sells 345,441 shares of APEI for $9,700,926.91 in three trades, reducing stake 22.6%

325 Capital LLC (Director) executed 3 separate sales totaling 345,441 shares (345.4K shares) for $9,700,926.91 on June 4–6, 2025, at prices ranging from $27.96 to $28.21, reducing holdings from 1,526,446 shares to 1,181,005 shares (1.18M shares). The sales occurred while the stock has appreciated 11.2% over 30 days and 20.2% over 90 days, trading at $28.25 current price near the 52-week high of $29.74. The director's cross-ticker track record shows 6 prior sells, though none of those prior sales at APEI have measurable 90-day outcomes; the most recent prior sales at this ticker (May 27–June 3) are themselves very recent and not yet evaluable. The company's fundamentals show $164.6M quarterly revenue, $8.9M net income, 4.0% annual growth, and a 20.77 P/E ratio. This represents a substantial reduction in a director's position during an extended rally.

325 Capital LLC (Director) sold 262,110 shares ($7.7M) over 3 days at avg $29.38; still holds 1,526,446 shares post-transaction.

Director 325 Capital LLC executed 3 separate sales totaling 262,110 shares for $7,701,876.17 between May 30 and June 3, 2025, reducing holdings by 14.7% from 1,788,556 to 1,526,446 shares. The sales occurred at prices ($29.45, $29.33, $29.32) near the stock's current level of $29.14 and well within the 52-week range of $12.30–$29.74. The stock has appreciated 17.4% over 30 days and 43.7% over 90 days from the transaction window. The insider retains a substantial 1,526,446-share position, indicating continued material ownership; the magnitude of the sale relative to pre-transaction holdings is significant but not liquidating. Prior trades at APEI (3 recent sales in late May) remain too recent for meaningful outcome measurement, and the broader cross-ticker track record does not yet establish a pattern specific to APEI's price momentum.

325 Capital LLC sells 134,054 shares of APEI across 3 transactions for $3,976,086.27 at blended avg $29.66

325 Capital LLC, a director at American Public Education Inc, executed 3 separate sales totaling 134,054 shares (134.1K shares) for $3,976,086.27 ($4.0M) on 2025-05-27 and 2025-05-29, reducing holdings from 1,189,066 to 1,055,012 shares (-11.3% vs pre-transaction holdings). The sales occurred at prices ranging from $29.36 to $29.83, near the 52-week high of $29.74, and the stock has appreciated 22.0% over the prior 30 days and 37.5% over the prior 90 days. The filer's cross-ticker track record shows 2 prior buys with a 100.00% 90-day win rate, though this metric reflects cumulative performance across multiple securities rather than predictive insight into APEI specifically. The magnitude and pace of the sale—eliminating 11.3% of the position—represents a material reduction in the director's stake at a price level consistent with recent strength.

10% owner 325 Capital LLC acquired 57,797 shares ($390.2K) in 2 purchases at blended $6.75 avg, raising stake to 2.03M shares

325 Capital LLC, already holding 10% of MPAA, deployed $390,209.48 across 2 separate purchases on consecutive days (August 27–28, 2024) to acquire 57,797 shares at an average price of $6.75 per share, increasing its position by 2.9% to 2,026,179 shares. This purchase occurs while the stock trades at $6.40 (current price), meaning the transaction prices of $6.73–$6.76 were executed above the current market level, and the stock has declined 37.1% from its 52-week high. MPAA reported a net loss of $-18.1M on quarterly revenue of $169.9M, indicating ongoing unprofitability, which provides important context for evaluating the significance of this incremental stake-building activity by the major shareholder.